EOFlow Co.

EOFlow is a wearable medical device company founded in 2011, with offices in Seoul, South Korea and San Jose, California, developing innovative drug delivery systems based on its proprietary pumping technology. The Company's first product is EOPatch, a fully-functional, wearable, disposable insulin pump for people with diabetes. EOFlow is also developing a proprietary "closed loop" insulin delivery platform including a wearable 'artificial pancreas' product that integrates a continuous glucose sensor and an insulin pump into one wearable module, which recently achieved FDA's Breakthrough Device Designation.